BMCM240100871351 24010507

Medical Laboratory Report
Patient Name : Mrs POOJA VERMA Patient UID No : BMCM240100871351

Age and Gender : 26 Years / Female PRN No : CL8784- 172
Category : OPD - MATA RAMABAI AMBEDKAR Registered On : 14 Feb 2024
MATERNITY HOME Sample UID No. 108285912
Referring Doctor : Self
Sample Processed at : MH DOMBIVALI SHAHSTRI NAGAR HOSPITAL
IMMUNOASSAY
Test Done Observed Value Units Biological Reference Interval
SERUM TESTOSTERONE 0.15 ng/mL 0-1

SERUM
CLIA
The measurement of total testosterone in serum can provide informa on to evaluate tes cular and adrenal func on. Its useful for the diagnosis of
hypergonadism and hyperpituitarism in men hirsu sm ,menorrhagic disorders and polycys c and polycys c ovarian syndrome in women
DR. SUYASH RASTOGI

(MD. PATHOLOGY)
~~~ END OF REPORT ~~~
Sample Collected On : 14.02.2024 13:40 Sample Accepted On : 14.02.2024 13:40 E18317
Results Authenticated : 14.02.2024 20:23 Results Reported : 14.02.2024 20:44 Printed On : 18.02.2024 14:41
Page 1 of 14
Category : OPD - MATA RAMABAI AMBEDKAR MATERNITY HOME Registered On : 14 Feb 2024
Referring Doctor : Self Sample UID No. 108285912
IMMUNOASSAY
FT3, Free Tri-Iodothyronine 2.98 pg/mL 1.86 - 6.43

SERUM
CMIA
FT4 (FREE THYROXINE) 1.12 ng/dL 0.70 - 1.90

Serum
CMIA
Test Descrip on:
• Thyroxine (T4) circulates in the blood as an equilibrium mixture of free and serum protein bound hormone. Thyroxine binding globulin (TBG), albumin
and pre-albumin bind approximately 75%, 10%
• And 15% of the total circula ng T4 respec vely.
• The binding of T4 by these proteins is such that less than 0.03% is present in the circula on as unbound, free T4.
• This small percentage of the total T4 represents the physiologically available hormone which is biologically ac ve.
Test Interpreta on:

• Levels of free T4 are elevated to a greater degree in toxic mul nodular Grave’s disease Goiter and excessive T4 therapy.
• Levels of free T4 are decreased in hypothyroidism.
Test Limita on:

Poten ally Interfering Substance
• Hemoglobin
• Bilirubin
• Triglycerides
• Protein
Re ex test:
• An -TG
• TPO an bodies
• TSH
References: Kit Insert (Alinity ci).
FSH (FOLLICLE STIMULATING HORMONE) 7.99 mIU/ml FFemale:

SERUM Follicular phase: 3.2 - 15.0
Ovula ng phase: 7.5 - 20.0
Luteal phase: 1.3 - 11.0
Post menopausal: 36.0 - 138.0
CMIA
Test Descrip on:

• Human Follicle S mula ng Hormone (FSH, follitropin) is a glycoprotein of approximately 30 000 daltons which, like luteinizing hormone (LH, lutropin),
human chorionic gonadotropin (hCG) and thyroid s mula ng hormone (TSH, thyrotropin), consists of two noncovalently associated subunits
designated a and ß. The a subunit of FSH contains 92 amino acids and is very similar to the a subunits of LH, hCG, and TSH.
• The ß subunit of FSH is unique and confers its immunological and func onal speci city.
• FSH and LH control growth and reproduc ve ac vi es of the gonadal ssues.
• FSH promotes follicular development in the ovary and gametogenesis in the tes s. The gonadotrophin cells of the anterior pituitary secrete both FSH
and LH in response to gonadotropin releasing hormone (LHRH or GnRH) from the medial basal hypothalamus. Both FSH and LH are secreted in a
pulsa le manner, with rapid uctua ons over the normal range. The pulsa lity of FSH is less pronounced than that of LH.
Page 2 of 14
IMMUNOASSAY
• Release of both FSH and LH from the pituitary is under nega ve feedback control by the Gonads.FSH in mature females acts to s mulate
development of the ovarian follicles.
• Circula ng FSH levels vary throughout the menstrual cycle in response to estradiol and progesterone.
• A small, but signi cant increase in circula ng FSH accompanies the mid-cycle LH surge. However, the physiological signi cance of this increase is
unknown. Circula ng levels of FSH decline in the luteal phase in response.
• To estradiol and progesterone produc on by the developing corpus luteum.
Test Interpreta on:

• FSH may also be elevated in Klinefelter’s syndrome (seminiferous tubule dysgenesis) or as consequence of Sertoli cell failure.
• In females, situa ons in which FSH is elevated and gonadal steroids are depressed include menopause, premature ovarian failure, and ovariectomy,
while with polycys c ovarian syndrome the LH/FSH ra o may be increased.
• Abnormal FSH concentra ons may also indicate dysfunc on of the hypothalamic-pituitary axis. In sexually mature adults, FSH de ciency, together
with low concentra ons of LH and sex steroids, may indicate panhypopituitarism.
• This can result either from a decrease in the release of GnRH or from a lack of response of the pituitary to GnRH. Determina on of serum FSH,
following administra on of GnRH, may allow di eren a on of these two condi ons.
• The use of oral contracep ves usually results in reduc on of gonadotropin levels due to nega ve feedback by these steroids.
Limita on of the Test:

• Poten al interference from hemoglobin, bilirubin, triglycerides, and protein was studied in the assay. These compounds showed = 10% interference in
the assay at the levels indicated.

• Hemoglobin
• Bilirubin
• Triglycerides
• Protein
Re ex test:
• LH
• Prolac n
PROLACTIN 35.50 ng / ml Female:

SERUM Nonpregnant : 2.8 - 29.2 ng/mL
Pregnant : 0.7 - 208.5 ng/mL
Post Menuposal : 1.8 - 20.3 ng/mL
CMIA
Test Descrip on:
• Human prolac n (hPRL) is a single chain polypep de of 199 amino acids and a molecular weight of approximately 23 000 daltons. Its existence as a
dis nct chemical en ty, separate from growth hormone, was established.
• Prolac n is produced by the anterior pituitary and its secre on is regulated physiologically by inhibitory and releasing factors of the hypothalamus.
Prolac n appears in the blood promptly a er administra on of thyrotropin-releasing hormone (TRH).
• The major physiologic ac on of prolac n is the ini a on and maintenance of lacta on in women.
Test Interpreta on:

• Hyperprolac nemia has been established as a common cause of infer lity and gonadal disorders in men and women. Prolac n has been shown to
Page 3 of 14
IMMUNOASSAY
inhibit the secre on of ovarian steroids and to interfere with follicle matura on and the secre on of LH and FSH in the human female. Measurement of
elevated serum prolac n levels may provide the rst quan ta ve evidence of pituitary dysfunc on. Quan ta on of prolac n levels is also of interest in
the evalua on and management of pa ents with amenorrhea and galactorrhea.
Test Limita on:

Poten al Cross Reactant
• FSH
• hCG
• hGH
• hPL
• LH
• TSH
Re ex Tests:
• TFT
• AMH
• Pooled prolac n (0,20,40)
T3 (Tri-iodothyronine) 1.18 ng/ml 0.7 - 2.04

SERUM Neonate : 0.73 - 2.88
6 Days-3 Month : 0.80 - 2.75
4 - 12 Month : 0.86 - 2.65
1 - 6 Years : 0.92 - 2.48
7 - 11 Years : 0.93 - 2.31
12 - 20 Years : 0.91 - 2.38
CMIA
Test Descrip on:
• 3,5,3' Triiodothyronine (T3) is a thyroid hormone with a molecular weight of 651 daltons1 and a half-life in serum of 1.5 days. T3 circulates in the
blood as an equilibrium mixture of free and protein bound hormone.
• T3 is bound to thyroxine binding globulin (TBG), prealbumin, and albumin. The actual distribu on of T3 among these binding proteins is controversial
as es mates range from 38-80% for TBG, 9-27% for prealbumin, and 11-35% for albumin.
Interpreta on Test:
• It has become apparent in recent years that T3 plays an important role in the maintenance of the thyroid state.
• Serum T3 measurements can be a valuable component of a thyroid screening panel in diagnosing certain disorders of thyroid func on as well as
condi ons caused by iodine de ciency.
• Under condi ons of strong thyroid s mula on, the T3 measurement provides a good es ma on of thyroid reserve.2Dietary iodine de ciency results
in inadequate produc on of thyroid hormones despite the presence of normal thyroid ssue. Elevated TSH associated with low T4 is normally
indica ve of hypothyroidism.

• Poten ally Interfering Endogenous Substances
• This study was performed on the Alinity i System. Poten al interference from hemoglobin, bilirubin, triglycerides, and protein was studied in the
assay. These compounds showed = 10% interference in the assay at the levels indicated.
• Hemoglobin
• Bilirubin
• Triglycerides
Page 4 of 14
IMMUNOASSAY
• Protein
Re ex test:
• FT4
• TSH
• ATAB(TPOAb+TGAb)
T4 (Thyroxine) 7.47 µg/dL 5.0 - 14.10

SERUM Neonate : 5.04 - 18.5
6 Days-3 Month : 5.41 - 17
4 - 12 Month : 5.67 - 16
1 - 6 Years : 5.95 - 14.7
7 - 11 Years : 5.99 - 13.8
12 - 20 Years : 5.91 - 13.2
CMIA
Test Descrip on:
• Thyroxine (T4) is an iodine-containing hormone which has a molecular weight of approximately 777 daltons and is secreted by the thyroid gland.
• T4 and its associate thyroid hormone T3 are responsible for regula ng diverse biochemical processes throughout the body which are essen al for
normal metabolic and neural Ac vity.
Interpreta on Test:
• T4 measurements have long been recognized as an aid in the assessment and diagnosis of thyroid status.
• Elevated T4 values are characteris cally seen in pa ents with overt hyperthyroidism, while T4 levels are generally depressed in pa ents with overt
hypothyroidism.
• Normal T4 levels accompanied by high T3 values are seen in pa ents with T3-thyrotoxicosis. T4 levels are altered by physiological or pathological
changes in TBP capacity.

• Poten ally Interfering Endogenous Substances
• This study was performed on the Alinity i System. Poten al interference from hemoglobin, bilirubin, triglycerides, and protein was studied in the
assay. These compounds showed = 10% interference in the assay at the levels indicated.

• Hemoglobin
• Bilirubin
• Triglycerides
• Protein
Re ex test:
• ATAB (TPO Ab+ATG Ab)
TSH 7.22 µIU/mL

SERUM
Page 5 of 14
IMMUNOASSAY
0.30 - 5.50
In Pregnant Women
First Trimester 0.1 - 2.5
Second Trimester 0.2 - 3.0
Third Trimester 0.3 - 3.0
Neonate : 0.70 - 15.2
6 Days-3 Month : 0.72 - 11
4 - 12 Month : 0.73 - 8.35
1 - 6 Years : 0.70 - 5.97
7 - 11 Years : 0.60 - 4.84
12 - 20 Years : 0.51 - 4.30
CMIA
Test Descrip on:
• Human thyroid s mula ng hormone (TSH) or thyrotropin is a glycoprotein with a molecular weight of approximately 28 000 daltons, synthesized by
the basophilic cells (thyrotropes) of the anterior pituitary.
• TSH is composed of two non covalently linked subunits designated alpha and beta. Alpha subunit of TSH is common to the luteinizing hormone (LH)
follicle s mula ng hormone (FSH) and human chorionic gonadotropin (hCG), the beta subunits of these glycoproteins are hormone speci c and confer
biological as well as immunological speci city.
• TSH s mulate the produc on and secrea on of the metabolically ac ve thyroid hormones, thyroxine (T4) And triiodothyronine (T3), by interac ng
with a speci c receptor on the thyroid cells surface. T3 and T4 ate responsible for regula ng diverse biochemical processes throughout the body which
are essen al for normal development and metabolic and neural ac vity.
Test Interpreta on:

• In cases of primary hypothyroidism, T3 and T4 levels are low and TSH levels are signi cantly elevated, In the case of pituitary dysfunc on, either due
to intrinsic hypothalamic or pituitary disease; i.e., central Hypothyroidism, normal or marginally elevated basal TSH levels are o en seen despite
signi cant. Secondary hypothyroidism typically results in an impaired TSH response of TRH, while in ter ary hypothyroidism the TSH response to TRH
may be normal, prolonged or exaggerated.
Test Limita on:

• Result should be used in conjunc on with other data; e.g., symptoms, result of other tests, and clinical Impressions.
• If the Alinity I TSH results are inconsistent with clinical evidence, addi onal tes ng is recommended to con rm the result.
• Suspected hyperthyroidism based on low or undetectable TSH levels should con rmed with addi onal
• Func on tes ng along with other clinical informa on.
• Specimens from pa ents who have received prepara on of mouse monoclonal an bodies for diagnosis or therapy may contain human an - mouse
an bodies (HAMA). Such specimens may show either falsely elevated or depressed values when tested with assay kits such as Alinity I TSH that employ
mouse monoclonal an bodies. Addi onal informa on may be required for diagnosis.
• Heterothallic an bodies in human serum can react with reagent immunoglobulins, interfering with in Vitro immunoassays. Pa ents rou nely exposed
to animal’s serum product can be prone to this Interference, and anomalous value may be required for diagnosis.
Re ex test:
• FT3 , FT4 , An TPO , An TG
Page 6 of 14
DR.RUPALI VASANT GADKARI
( DCP DNB PATH )
Page 7 of 14
ANTI THYROID ANTIBODY

An TPO An bodies (AMA) 4.48 U/mL Posi ve: >=5.61
Nega ve: < 5.61
SERUM
CMIA
DR.SAURABH GUJRATHI
( MD PATHOLOGY )

Krsnaa Diagnostics Ltd.

(Formerly Krsnaa Diagnostics Pvt. Ltd.)
S.No.243, A-Hissa No.6/6 CTS No.4519, Near Mayur Trade Centre, Chinchwad, Pune- 411 019 , India
020 27350025 / 26 / 27 | info@krsnadiagnostics.com
Page 8 of 14
www.krsnaadiagnostics.com
ANTI THYROID ANTIBODY)

An Thyroglobulin An body (ATG) 11.62 lU/mL <4.11 lU/mL
SERUM
Method- CMIA
DR.SAURABH GUJRATHI
( MD PATHOLOGY )


Page 9 of 14
www.krsnaadiagnostics.com
IMMUNOASSAY
PARATHORMONE 19.20 pg/ml 15.0 - 68.3 PG/ML

SERUM
CLIA
DR.MANISH D KAREKAR
( MD-PATHOLOGY)
COO- LAB MEDICINE/PATHOLOGY

www.krsnaadiagnostics.com Page 10 of 14
Category : OPD - MATA RAMABAI AMBEDKAR Registered On : 14 Feb 2024
MATERNITY HOME Sample UID No. 20027539
Referring Doctor : Self
IMMUNOASSAY
Estrogen 11.90 pg/ml Males : < 87
Females
Follicular phase : 15 - 112

Preovulatory phase : 136 -
251
Luteal phase : 48 - 172
Menopausal phase : 10 -
66
Hormonal contracep ves :
15 - 95
E.C.L.I.A.
DR.JITENDRA SURU
( M.B:B.S, M.D - Pathology )
Sample Collected On : 17.02.2024 00:54 Sample Accepted On : 17.02.2024 00:54 charu

www.krsnaadiagnostics.com Page 11 of 14
HEMATOLOGY
COMPLETE BLOOD COUNT

Haemoglobin 13.30 g/dl 11.0 - 16.0
Photometric
Total Leucocyte Count 6.16 x 10^3 /µL 4.0- 11.0
Electrical impedence
Total Erythrocyte Count 4.55 x 10^6 /µL 3.5 - 5.5
Platelet count 281.00 x 10^3 /µL 150 - 410
MPV 12.80
Calculated
PCT 0.36 %
Electrical Impedence
PDW 31.90 %
Electrical Impedence
R.B.C. Indices
P.C.V. 38.50 % 35 - 48
M.C.V. 84.40 fL 82 - 95.0
Measured
M.C.H. 29.10 pg 25 - 33
Measured
M.C.H.C 34.50 gm/dl 31.5 - 34.5
Calculated
R.D.W. CV 16.10 % 11.0 - 16.0
Calculated
Differential W.B.C. Count
Neutrophils 54.30 % 40 - 70
Cytochemistry & impedence/PS
Lymphocytes 33.20 % 20 - 40
Eosinophils 5.00 % 0-6
DR.S. SAMADDAR
(MBSS, MD PATHOLOGY)

Page 12 of 14
HEMATOLOGY
COMPLETE BLOOD COUNT

Differential W.B.C. Count
Monocytes 6.50 % 0-8
Basophils 1.00 % 0-1
Absolute Count
Absolute Neutrophil Count 3.35 x 10^3 /µL 1.5 - 8.0
Calculated
Absolute Lymphocyte Count 2.04 x 10^3 /µL
Calculated
Absolute Eosinophil Count 0.31 x 10^3 /µL 0.04 - 0.44
Calculated
Absolute Monocyte Count 0.40 x 10^3 /µL
Calculated
Absolute Basophil Count 0.06 x 10^3 /µL
Calculated
Peripheral Smear Findings
Abnormali es of Erythrocytes Normocy c Normochromic
Abnormali es of Leucocytes Within normal limits
Platelets on smear Adequate on smear.
Test performed on fully automated 5 part di eren al cell counter.
DR.S. SAMADDAR
(MBSS, MD PATHOLOGY)

Page 13 of 14
BIOCHEMISTRY
LH (LUETENISING HORMONE). 8.06 mIU/ml Female:

SERUM Follicular phase: 1.2 - 12.5
Ovula on phase: 12.0 - 82.0
Luteal phase: 0.4 - 19.0
Post menopausal: 14.0 - 48.0
CMIA
Test Descrip on:
• Human luteinizing hormone (LH, lutropin) is a glycoprotein hormone with two dissimilar subunits (a and ß).
• The a-subunit is essen ally iden cal to the a-subunits of follicle s mula ng hormone (FSH, follitropin), thyroid s mula ng hormone (TSH,
thyrotropin), and human chorionic gonadotropin (hCG).
• The ß-subunit is considerably di erent from that of FSH and TSH. However, the ß-subunits of LH and hCG are very similar. LH, together with FSH, is
secreted by the gonadotroph cells in the pituitary in response to the secre on of the gonadotropin releasing hormone (LHRH, GnRH) from the medial
basal hypothalamus.
• Ovarian steroids, principally estrogens, modulate the secre on of LH and FSH which in turn regulate the menstrual cycle in females.
• When the follicle and the ovum contained within it, reach maturity, a surge of LH causes the follicle to rupture releasing the ovum. The follicular
remnant is transformed into a corpus luteum, which secretes progesterone and estradiol.
Interpreta on Test:
• Determina on of the concentra on of LH is essen al for the predic on of ovula on, in the evalua on of infer lity, and the diagnosis of pituitary and
gonadal disorders.
• Increasing concentra ons of LH precede ovula on and in cases in which the period of op mal fer lity needs to be de ned for the ming of
intercourse or ar cial insemina on, daily concentra ons of LH are important for the predic on of ovula on.
• More frequent sampling is required if the precise me of follicular rupture is needed for egg aspira on for in vitro fer liza on. At menopause, or
following ovariectomy in women, concentra ons of estrogens decline to low levels.
• The lowered concentra ons of estrogens result in a loss of the nega ve feedback on gonadotropin release. The consequence is an increase in the
concentra ons of LH
and FSH.
Test Limita on:

Poten ally Interfering Substances are
• Bilirubin
• Protein
• Triglycerides
• Hemoglobin
Re ex Tests:
• FSH,
• Sr. Testosterone
DR. SUYASH RASTOGI

(MD. PATHOLOGY)
Page 14 of 14

BMCM240100871351 24010507

Uploaded by

Copyright:

Available Formats

You might also like

BMCM240100871351 24010507

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

BMCM240100871351 24010507

Uploaded by

Copyright:

Available Formats

Medical Laboratory Report

Patient Name : Mrs POOJA VERMA Patient UID No : BMCM240100871351

SERUM TESTOSTERONE 0.15 ng/mL 0-1

DR. SUYASH RASTOGI

FT3, Free Tri-Iodothyronine 2.98 pg/mL 1.86 - 6.43

FT4 (FREE THYROXINE) 1.12 ng/dL 0.70 - 1.90

Test Interpreta on:

Test Limita on:

References: Kit Insert (Alinity ci).

FSH (FOLLICLE STIMULATING HORMONE) 7.99 mIU/ml FFemale:

Test Descrip on:

Test Interpreta on:

Limita on of the Test:

Poten ally Interfering Substance

References: Kit Insert (Alinity ci).

PROLACTIN 35.50 ng / ml Female:

Test Interpreta on:

Test Limita on:

References: Kit Insert (Alinity ci).

T3 (Tri-iodothyronine) 1.18 ng/ml 0.7 - 2.04

Limita on of the Test:

References: Kit Insert (Alinity ci).

T4 (Thyroxine) 7.47 µg/dL 5.0 - 14.10

Limita on of the Test:

Poten ally Interfering Substance

References: Kit Insert (Alinity ci).

TSH 7.22 µIU/mL

Test Interpreta on:

Test Limita on:

References: Kit Insert (Alinity ci).

ANTI THYROID ANTIBODY

~~~ END OF REPORT ~~~

Sample Collected On : 17.02.2024 00:54 Sample Accepted On : 17.02.2024 00:54 E13564

Krsnaa Diagnostics Ltd.

ANTI THYROID ANTIBODY

~~~ END OF REPORT ~~~

Sample Collected On : 17.02.2024 00:54 Sample Accepted On : 17.02.2024 00:54 E13564

Krsnaa Diagnostics Ltd.

PARATHORMONE 19.20 pg/ml 15.0 - 68.3 PG/ML

Krsnaa Diagnostics Ltd.

Estrogen 11.90 pg/ml Males : < 87

Follicular phase : 15 - 112

Krsnaa Diagnostics Ltd.

COMPLETE BLOOD COUNT

~~~ END OF REPORT ~~~

Sample Collected On : 14.02.2024 13:25 Sample Accepted On : 14.02.2024 13:25 E18578

COMPLETE BLOOD COUNT

~~~ END OF REPORT ~~~

Sample Collected On : 14.02.2024 13:25 Sample Accepted On : 14.02.2024 13:25 E18578

LH (LUETENISING HORMONE). 8.06 mIU/ml Female:

Test Limita on:

References: Kit Insert (Alinity ci).

DR. SUYASH RASTOGI

You might also like

~ END OF REPORT ~

~ END OF REPORT ~

~ END OF REPORT ~

~ END OF REPORT ~